Submitted by Anonymous (not verified) on 23 October 2026 - 11:06
Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 8, Status: Authorised